Antibacterial activity of recently approved antibiotics against methicillin-resistant Staphylococcus aureus (MRSA) strains: A systematic review and meta-analysis

Table 4 Antibacterial activity of telavancin against MRSA isolates based on year groups

Telavancin		MIC₅₀	MIC₉₀	MIC_90/50	Susceptibility rate (%)
2010–2015	Median	0.25	0.25	2	100
	Min.	0.03	0.06	2	100
	Max.	0.25	0.5	1	100
2016–2020	Median	0.032	0.06	2	100
	Min.	0.03	0.06	1	100
	Max.	0.06	0.064	2	100

ISSN: 1476-0711